Emergency Medicine: Open Access

Emergency Medicine: Open Access
Open Access

ISSN: 2165-7548

Evgenyia Ranneva

Evgenyia Ranneva
Skin Tech Pharma Group,
17486 Castelló d'Empúries, Girona
Spain

Publications
  • Short Communication
    The Use of Hyaluronidase to Treat the Excess of Cross-Linked Hyaluronic Acid Following Aesthetic Medicine Procedures: A Practical Point of View
    Author(s): Evgenyia RannevaEvgenyia Ranneva

    Polymers formed by hyaluronic acid are generally catalyzed by Hyaluronidase and the product contains oligomers. Hydrolysis of the bond present in between the N-acetyl-Dglucosamine and D-glucuronic acid is responsible for such chemical process. Huge literature support is present supporting the application of this process for reducing cellulitis fibrosis. In the recent times, potential granulomatous reactions are being treated through this process as well as aiding in dissolving excess hyaluronic acid filler. Implication of hyaluronidase includes simple jabbing of hyaluronidase enzyme prepared with sterile solution. Generally, the solution consist sterile lyophilized hyaluronidase preparation with sterile saline medium. After conducting the allergy testing direct injection can be given to the problem area for treatment. Assessment of allergy is mandatory as the enzyme hyaluronidase prot.. View More»
    DOI: 10.4172/2165-7548.1000357

    Abstract PDF

Relevant Topics

Top